The Pain is Real: Fibromyalgia in Our Genes
“We are not drug seeking. Trust me, I would not be there if my pain wasn’t approaching critical levels.”
That is what one BC patient told us in our 2025 community survey about seeking care for severe pain.
People living with fibromyalgia know this kind of disbelief all too well: pain dismissed as exaggeration, symptoms blamed on anxiety or weight, patients treated as “drug seeking” when they ask for help.
September is Pain Awareness Month, and this year there is important new science to talk about.
The largest genetic study of fibromyalgia ever conducted has added powerful new evidence of something patients have known all along:
Fibromyalgia is real. And its biology is written, in part, in our genes.
2.5 million people. 26 genetic regions.
Published in Nature Medicine in July 2026, the study brought together 53 researchers and genetic data from approximately 2.5 million people across six countries.
Researchers identified 26 regions of the genome associated with fibromyalgia, forming the clearest genetic picture of the illness to date.
They also found that genes near these variants were particularly active in nervous system cells, giving researchers important new clues about the biology of fibromyalgia. The study also identified potential avenues for future treatment research, including GPR52, a drug target already being investigated in other neurological research.
This doesn’t mean researchers have found a single “fibromyalgia gene.” They haven’t.
It means many genetic differences appear to contribute to fibromyalgia risk, and researchers now have new places to look for answers.
Why this matters to our community
Fibromyalgia has spent decades fighting for legitimacy.
Our community is still living with the consequences.
In the ME|FM Society of BC’s 2025 Community Survey, more than half of respondents reported living with fibromyalgia. Patients described being dismissed, having symptoms attributed to psychological causes, and struggling to have severe pain taken seriously.
One respondent described what years of dismissal had cost them:
“I lost years and years of my life and my saving potential.”
Another was refused a rheumatology referral because their GP believed their pain was due to PTSD.
Disbelief isn’t just hurtful. It can delay diagnosis and treatment, affect access to disability support, and leave patients questioning their own experiences.
Patients already knew their pain was real
There is something uncomfortable about celebrating scientific evidence that fibromyalgia is “real.”
Patients shouldn’t need genetic evidence to prove their pain exists.
But research like this can help change the conversation. It gives researchers new biological pathways to investigate and potentially new targets for treatment. And it adds powerful evidence against the idea that fibromyalgia is simply psychological, imagined or a failure of willpower.
There is still a great deal to learn. Finding genetic associations isn’t the same as finding a cure or treatment.
But this Pain Awareness Month, new science brings new hope and new paths toward answers.
Learn more about what BC patients told us in the ME|FM Society of BC’s 2025 Community Survey.
Comments